Research programme: Kv1.3 potassium channel inhibitors - 4SC

Drug Profile

Research programme: Kv1.3 potassium channel inhibitors - 4SC

Latest Information Update: 09 Oct 2013

Price : $50

At a glance

  • Originator 4SC
  • Class Small molecules
  • Mechanism of Action Kv1.3 potassium channel inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Autoimmune disorders; Multiple sclerosis

Most Recent Events

  • 09 Oct 2013 Early research is ongoing in Germany
  • 11 Mar 2011 This programme is in active development
  • 26 Mar 2009 In vitro pharmacodynamics data from a research study presented at the 237th American Chemical Society National Meeting (237th-ACS-2009)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top